Across the recent three months, 5 analysts have shared their insights on Health Catalyst (NASDAQ:HCAT), expressing a variety of opinions spanning from bullish to bearish.
The table below provides a snapshot of their recent ratings, showcasing how sentiments have evolved over the past 30 days and comparing them to the preceding months.
| Bullish | Somewhat Bullish | Indifferent | Somewhat Bearish | Bearish | |
|---|---|---|---|---|---|
| Total Ratings | 1 | 3 | 1 | 0 | 0 |
| Last 30D | 0 | 1 | 0 | 0 | 0 |
| 1M Ago | 0 | 0 | 1 | 0 | 0 |
| 2M Ago | 0 | 1 | 0 | 0 | 0 |
| 3M Ago | 1 | 1 | 0 | 0 | 0 |
Providing deeper insights, analysts have established 12-month price targets, indicating an average target of $11.2, along with a high estimate of $16.00 and a low estimate of $7.00. A negative shift in sentiment is evident as analysts have decreased the average price target by 5.08%.
Breaking Down Analyst Ratings: A Detailed Examination
The...
Login or create a forever free account to read this news
Sign up/Log in